| Name | Title | Contact Details |
|---|
Q2 Holdings, Inc. (Q2) is a leading provider of secure, cloud-based virtual banking solutions, headquartered in Austin, Texas. Q2 enables regional and community financial institutions, or RCFIs, to deliver a robust suite of integrated virtual banking services and engage more effectively with their retail and commercial account holders who expect to bank anytime, anywhere and on any device. Q2`s solutions are often the most frequent point of interaction between its RCFI customers and their account holders. As such, Q2 purpose-built its solutions to deliver a compelling, consistent user experience across digital channels and drive the success of its customers by extending their local brands, enabling improved account holder retention and creating incremental sales opportunities.
mdPassport is a Toronto, ON-based company in the Software and Internet sector.
Reciprocity Inc develops cutting-edge consumerized enterprise software, most recently for the Governance, Risk, and Compliance (GRC) marketspace. Our hosted GRC solution ZenGRC, developed with Google, helps Compliance and Audit Managers get beyond ...
Avatech Solutions, Inc. is a Owings Mills, MD-based company in the Software and Internet sector.
Businesses are finding themselves faced with transformative change, from cloud technology to big data. No better example than the life sciences industry which is transforming from a data-driven clinical enterprise to an information-driven one. As the EDC specialists OmniComm understands the power that an information-driven clinical enterprise can bring to your clinical research organization. OmniComm is the only company that provides our clients with a choice of best-of-breed EDC platforms that are purpose-built for their unique clinical research environments – Early Phase, Late Phase, Phase I-IV, device trials, Investigator Initiated. We bring the most advanced open and interoperable EDC platforms to our clients; through our innovative cloud technology and advanced API web services we provide our clients with information to make insight driven clinical data-based critical decisions, bringing medical therapies to patients faster with lower risk. OmniComm provides comprehensive solutions for clinical research with an extensive global experience from over 4,800 clinical trials. 4 of the 5 top CROs and 7 of the 10 largest Phase I Clinics run OmniComm EDC technologies.